Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

BIOTRON LIMITED

INVESTOR PRESENTATION - BIOTRON LIMITED

ASX:BIT

BIOTRON LIMITED

Health Care

Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.

Read more

Market Cap

56.86m

Price at Close

$0.081

4w avg. Volume

1.83m

4w avg. Turnover

$171.03k

Announcements
announcementt+2 movementdate
  • Quarterly Activities Report

    Commitments test entity quarterly reports · Market sensitive

  • -

    29 Oct 2020

-

29 Oct 2020
  • Quarterly Cashflow Report

    Commitments test entity quarterly reports · Market sensitive

  • -

    29 Oct 2020

-

29 Oct 2020
  • BIT225 HIV-1 Immunomodulatory Paper Published

    Progress Report

  • -1.04%

    14 Oct 2020

-1.04%

14 Oct 2020
  • Presentation to Investors

    Periodic Reports

  • -1.04%

    14 Oct 2020

-1.04%

14 Oct 2020
  • Annual Report and Notice of Annual General Meeting

    Periodic Reports

  • +2.22%

    08 Oct 2020

+2.22%

08 Oct 2020
  • Biotron Compounds Show Activity Against SARS-CoV-2 Virus

    Stock Exchange Announcement · Market sensitive

  • -4.55%

    06 Sep 2020

-4.55%

06 Sep 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • +15.79%

    03 Sep 2020

+15.79%

03 Sep 2020
  • Pause in Trading

    Stock Exchange Announcement · Market sensitive

  • +15.79%

    03 Sep 2020

+15.79%

03 Sep 2020
  • Full Year Statutory Accounts

    Periodic Reports · Market sensitive

  • -5.05%

    27 Aug 2020

-5.05%

27 Aug 2020
  • Appendix 4G and Corporate Governance Statement

    Periodic Reports

  • -5.05%

    27 Aug 2020

-5.05%

27 Aug 2020
Market Data

Current Price

$0.081

52WK HIGH

$0.185

52WK LOW

$0.05

1YR RETURN

+15.07%

1YR RETURN VS. SECTOR

-4.52%

90 DAY RETURN

-13.40%

ASX RANK

983

/2,011

SECTOR RANK

22

/47

SHARES OUTSTANDING

701.93m
ASX:BIT

BIOTRON LIMITED

Health Care

Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.

Read more

Market Cap

56.86m

Price at Close

$0.081

4w avg. Volume

1.83m

4w avg. Turnover

$171.03k

ASX:BIT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.